PharmaShots Weekly Snapshot (April 22-26, 2019)
Published: April 26,2019 | Tags: Novo Nordisk, Files, MAA, Semaglutide, European Medicines Agency, EMA, Type 2 Diabetes
Published: April 25,2019 | Tags: Gilead, Reports, Results, Selonsertib, P-III, STELLAR 3, Study, Bridging Fibrosis, F3, NASH
3.Takeda Files NDA for Cabometyx (cabozantinib) to MHLW for Advanced Renal Cell Carcinoma in Japan
Published: April 25,2019 | Tags: Takeda, Files, NDA, Cabometyx, cabozantinib, MHLW, Advanced Renal Cell Carcinoma, Japan
Published: April 25,2019 | Tags: Merck, Reports, Updated, Results, Keytruda, pembrolizumab, P-III, KEYNOTE-062, Study, 1L, Treatment, Advance Gastric Cancer
Published: April 25,2019 | Tags: Salix (Bausch Health), Signs, License Agreement, Mitsubishi Tanabe Pharma, MT-1303, amiselimod, Inflammatory Bowel Disease, Ulcerative Colitis
6.B. Braun Launches its Heparin Sodium Prefilled Syringe in the US
Published: April 24,2019 | Tags: B. Braun, Launches, Ready-To-Use, Prefilled Syringe, Heparin Sodium Injection
Published: April 25,2019 | Tags: Eli Lilly, Facilitates, Withdrawal, Lartruvo, olaratumab, Global Market, Advanced Soft Tissue Sarcoma
8. ADC Therapeutics Signs a License Agreement with Adagene for its SAFEbody Technology
Published: April 24,2019 | Tags: ADC Therapeutics, Signs, License Agreement, Adagene, SAFEbody Technology
Published: April 24,2019 | Tags: Perelman School of Medicine, Signs, Research, Development, Agreement, Sensus Healthcare, Sculptura Intraoperative Radiation Therapy System
10.Takeda Signs a Licensing Option Agreement with Emendo Biotherapeutics for its OMNI Nuclease Program
Published: April 24,2019 | Tags: Takeda, Signs, Licensing Option Agreement, Emendo Biotherapeutics, OMNI Nuclease Program
Published: April 23,2019 | Tags: GSK, Signs, Exclusive, Worldwide, License, Agreement, Fulcrum Therapeutics, Develop, Commercialize, Losmapimod, Facioscapulohumeral Muscular Dystrophy
12. AbbVie’s Skyrizi (risankizumab-rzaa) Receives FDA’s Approval for Moderate to Severe Plaque Psoriasis
Published: April 23,2019 | Tags: AbbVie, Skyrizi (risankizumab-rzaa), Receives, FDA, Approval, Moderate, Severe, Plaque Psoriasis
13. OncoSec Initiates a Triple Combination Immunotherapy Trial for Squamous Cell Head and Neck Cancer
Published: April 23,2019 | Tags: OncoSec, Initiates, Triple Combination, Study, Immunotherapies, Squamous Cell Head and Neck Cancer
14.Teva Discontinues its P-III ENFORCE Study of Fremanezumab for Episodic Cluster Headache
Published: April 23,2019 | Tags: Teva, Discontinues, P-III, ENFORCE Study, Fremanezumab, Episodic Cluster Headache
15. BAROnova’s TransPyloric Shuttle Device Receives FDA’s Approval for the Treatment of Obesity in Adult
Published: April 23,2019 | Tags: BAROnova, TransPyloric Shuttle, Receive, FDA, Approval, Treatment, Obesity, Adults
16.NuVasive Reports Results of Cohere Porous PEEK Implants for Degenerative Cervical Disc
Published: April 22,2019 | Tags: NuVasive, Reports, Results, Cohere Porous PEEK Implants, Study, Patients, Degenerative Cervical Disc
17. Alder BioPharmaceuticals Reports FDA’s Acceptance of BLA for Eptinezumab to Prevent Migraine
Published: April 22,2019 | Tags: Alder BioPharmaceuticals, Reports, FDA, Acceptance, BLA, Eptinezumab, Prevent, Migraine
Published: April 22,2019 | Tags: Eli Lilly, Sell, Chinese Rights, Antibiotics, Manufacturing Facility, Eddingpharm, $375M
19.Roche Launches Ventana HER2 Dual ISH CDx for the Identification of Breast and Gastric Cancer
Published: April 23,2019 | Tags: Roche, Launches, Ventana HER2 Dual ISH, CDx, Identification, Breast, Gastric Cancer
Published: April 22,2019 | Tags: Lilly, Reports, Results, Taltz, ixekizumab, P-III, COAST-X, Study, Non-Radiographic Axial Spondyloarthritis
Published: April 22,2019 | Tags: Merck, Keytruda, pembrolizumab, Inlyta, axitinib, Receive, FDA, Approval, 1L, Treatment, Advanced Renal Cell Carcinoma, RCC
Published: April 22,2019 | Tags: Lilly, Signs, Global, Research, Licensing, Agreement, Avidity Biosciences, Develop, New Therapies, Immunology
Published: April 18,2019 | Tags: TELA Bio, Restella Reconstructive BioScaffolds, Receives, FDA, 510(k), Clearance, Reconstructive Surgery
Published: April 19,2019 | Tags: Alvogen, Voluntary, Recalls, Two, Lots, Fentanyl Transdermal System, Product Mislabeling